Track NAMS and 10,000+ stocks
Create a free account to build watchlists, compare peers, and value any stock.
- Build and track watchlists
- Compare against peers
- Earnings & price alerts
No credit card required
Create a free account to build watchlists, compare peers, and value any stock.
No credit card required
NAMS - NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS) has a earnings per share of -$0.34, down 13.3% over the past year.
Latest EPS (Actual)
-$0.34
Beat Rate
62.5%
Most Recent
Beat
| Date | Estimated EPS | Actual EPS | Result | Surprise % |
|---|---|---|---|---|
| May 2026 | -$0.47 | -$0.34 | Beat | +27.93% |
| Feb 2026 | -$0.40 | -$0.63 | Miss | -57.50% |
| Nov 2025 | -$0.38 | -$0.41 | Miss | -7.89% |
| Aug 2025 | -$0.44 | -$0.15 | Beat | +65.91% |
| May 2025 | -$0.44 | -$0.30 | Beat | +31.82% |
| Feb 2025 | -$0.96 | -$0.93 | Meet | +3.12% |
| Nov 2024 | -$0.45 | -$0.16 | Beat | +64.44% |
| Aug 2024 | -$0.52 | -$0.38 | Beat | +26.92% |
Earnings per share (EPS) is a company's net profit divided by its number of outstanding shares. It shows how much profit is attributable to each share and is one of the most closely watched gauges of profitability.